WALTHAM, Mass.--(BUSINESS WIRE)--
PerkinElmer,
Inc. (NYSE:PKI), a global leader committed to innovating for a
healthier world , today announced that Pascale Witz, MBA, MSc, has been
elected to its Board of Directors, effective immediately.
"We would like to extend a warm welcome to Pascale as the newest member
of our Board," said Robert Friel, chairman and chief executive of
PerkinElmer. "She brings a wide range of commercial healthcare and
strategic management experience across the pharmaceutical, medical
device, and diagnostics industries, and I am confident that her
leadership will be invaluable in helping drive the future direction of
the Company."
Witz has more than 30 years of global experience, most recently serving
as executive vice president, Global Diabetes and Cardiovascular for
Sanofi, S.A. Prior to Sanofi, she held several leadership positions
during her 17 years with GE Healthcare, including the role of president
and CEO of its medical diagnostics division. She began her career in
research before moving to a marketing role at Becton Dickinson France in
1991 and to GE Healthcare in 1996.
Witz currently serves on the Board of Directors of Horizon Pharma Plc,
Regulus Therapeutics, Inc., Fresenius Medical Care AG & Co. KGaA,
Savencia SA, and French-American Foundation-France. Witz received her
MSc in biochemistry from the Institut National des Sciences Appliquées
de Lyon, France and an MBA in economics and marketing from INSEAD,
Fontainebleau, France.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader
committed to innovating for a healthier world. Our dedicated team of
9,000 employees worldwide is passionate about providing customers with
an unmatched experience as they help solve critical issues especially
impacting the diagnostics, discovery and analytical solutions markets.
Our innovative detection, imaging, informatics and service capabilities,
combined with deep market knowledge and expertise, help customers gain
earlier and more accurate insights to improve lives and the world around
us. The Company reported revenue of approximately $2.1 billion in 2016,
serves customers in more than 150 countries, and is a component of the
S&P 500 Index. Additional information is available through
1-877-PKI-NYSE, or at www.perkinelmer.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171030005859/en/
PerkinElmer, Inc.
Brian Willinsky, +1- 781-663-5728
brian.willinsky@perkinelmer.com
Source: PerkinElmer, Inc.
News Provided by Acquire Media